ACR适宜性标准®:卵巢癌筛查
本指南由美国放射学会(ACR)基于随机与观察性试验数据制定,评估影像学在平均风险和高风险女性卵巢癌筛查中的作用。对平均风险绝经后女性,现有证据不足以推荐盆腔超声筛查,随机对照试验未显示死亡率获益;高风险女性行盆腔超声筛查在某些临床情况下可能合适,但相关数据有限。
要点
- 平均风险绝经后女性:现有证据不足以推荐卵巢癌筛查,随机对照试验未显示死亡率获益。
- 高风险女性:盆腔超声筛查在某些临床情况下可能合适,但缺乏大型随机试验数据。
- 指南采用RAND/UCLA适宜性方法和GRADE对影像与治疗操作进行适宜性评级。
核心结论
- 对平均风险绝经后女性,现有证据不足以推荐卵巢癌筛查,随机对照试验未显示死亡率获益。
- 高风险女性行盆腔超声筛查在某些临床情况下可能合适,但相关数据有限,因缺乏大型随机试验。
研究设计与样本
- 美国放射学会(ACR)适宜性标准指南,由多学科专家小组每年审查,采用RAND/UCLA适宜性方法和GRADE对影像与治疗操作进行适宜性评级。
- 证据来源于随机和观察性试验,评估影像学在平均风险和高风险女性卵巢癌筛查中的作用。
诊断标准与关键数值
- 对平均风险绝经后女性,盆腔超声筛查的证据不足以推荐卵巢癌筛查。
- 随机对照试验未显示平均风险绝经后女性盆腔超声筛查的死亡率获益。
- 高风险女性盆腔超声筛查在某些临床情况下可能合适,但相关数据有限。
临床应用与阅片要点
- 对平均风险绝经后女性,现有证据不足以推荐卵巢癌筛查。
- 高风险女性行盆腔超声筛查在某些临床情况下可能合适,但相关数据有限。
- 证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
局限性
- 对平均风险绝经后女性,现有证据不足以推荐卵巢癌筛查。
- 高风险女性盆腔超声筛查的相关数据有限,因缺乏大型随机试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
There has been much interest in the identification of a successful ovarian cancer screening test, in particular, one that can detect ovarian cancer at an early stage and improve survival. We reviewed the currently available data from randomized and observational trials that examine the role of imaging for ovarian cancer screening in average-risk and high-risk women. We found insufficient evidence to recommend ovarian cancer screening, when considering the imaging modality (pelvic ultrasound) and population (average-risk postmenopausal women) for which there is the greatest available published evidence; randomized controlled trials have not demonstrated a mortality benefit in this setting. Screening high-risk women using pelvic ultrasound may be appropriate in some clinical situations; however, related data are limited because large, randomized trials have not been performed in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Pandharipande PV, Lowry KP, Reinhold C, et al. ACR Appropriateness Criteria® Ovarian Cancer Screening. J Am Coll Radiol. 2017. PMID: 29101987. doi:10.1016/j.jacr.2017.08.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。